The effects of macrophage migratory inhibitory factor on acute-phase protein production in primary human hepatocytes

N.M. Wheelhouse, N. Dowidar, C.H. Dejong, O.J. Garden, J.J. Powell, M.D. Barber, K. Sangster, J.P. Maingay, J.A. Ross

Research output: Contribution to journalArticleAcademicpeer-review


Macrophage inhibitory factor (MIF) is a pituitary peptide released during the physiological stress response, a T-cell product secreted during the antigen-specific response and a pro-inflammatory macrophage cytokine secreted after LPS stimulation. It has become apparent that MIF is central to the regulation of the inflammatory response and is implicated in the pathogenesis of a variety of acute and chronic inflammatory conditions. This is, at least in part, due to the apparent counter-regulation of the anti-inflammatory actions of glucocorticoids, including the reversal of glucocorticoid-mediated IL-6 release inhibition. This study examines the effect of recombinant MIF on regulation of the acute phase response in isolated human hepatocytes. MIF alone increased C-reactive protein (CRP) release in a dose-dependent manner < or = 0.1 ng/ml after which the effects of MIF were attenuated. In combination with IL-6 both CRP and and alpha-1-antichymotrypsin (ACT) release were increased above levels found with either IL-6 or MIF treatment alone. Dexamethasone attenuated the effects of MIF upon CRP production but increased the MIF stimulated release of ACT. The study demonstrates that the effects of MIF upon the acute phase response are complex and can differentially modulate the production of acute phase proteins depending on the presence of other factors.
Original languageEnglish
Pages (from-to)957-961
JournalInternational Journal of Molecular Medicine
Issue number5
Publication statusPublished - 1 Jan 2006

Cite this